ID

36605

Beschrijving

Icotinib in Advanced Non-small Cell Lung Cancer (NSCLC) With Hepatic Insufficiency; ODM derived from: https://clinicaltrials.gov/show/NCT02062515

Link

https://clinicaltrials.gov/show/NCT02062515

Trefwoorden

Versies (1)
  1. 26-05-19 26-05-19 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

26 mei 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Non-small Cell Lung Cancer NCT02062515

Engels

Eligibility Non-small Cell Lung Cancer NCT02062515

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed diagnosis of iiib/iv stage nsclc patients who are not suitable for surgery or radiotherapy
Beschrijving

Non-Small Cell Lung Carcinoma TNM clinical staging | Patients Inappropriate Operative Surgical Procedures | Patients Inappropriate Therapeutic radiology procedure

Datatype

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C3258246
UMLS CUI [2,1]
C0030705
UMLS CUI [2,2]
C1548788
UMLS CUI [2,3]
C0543467
UMLS CUI [3,1]
C0030705
UMLS CUI [3,2]
C1548788
UMLS CUI [3,3]
C1522449
ecog performance status points (ps) is 0-2
Beschrijving

ECOG performance status

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
liver function:
Beschrijving

Liver function

Datatype

boolean

Alias
UMLS CUI [1]
C0232741
a (mild hepatic dysfunction):
Beschrijving

Liver dysfunction, mild

Datatype

boolean

Alias
UMLS CUI [1]
C3279149
a1) total bilirubin within normal limit (uln), while ast> uln;
Beschrijving

Serum bilirubin normal | Aspartate aminotransferase increased

Datatype

boolean

Alias
UMLS CUI [1]
C0428443
UMLS CUI [2]
C0151904
a2) total bilirubin within1.0-1 .5 × uln;
Beschrijving

Elevated total bilirubin

Datatype

boolean

Alias
UMLS CUI [1]
C0741494
b (moderate hepatic dysfunction): total bilirubin within1.5-3 .0 × uln
Beschrijving

Liver Dysfunction Moderate | Elevated total bilirubin

Datatype

boolean

Alias
UMLS CUI [1,1]
C0086565
UMLS CUI [1,2]
C0205081
UMLS CUI [2]
C0741494
no malabsorption or other gastrointestinal disorders effecting drug absorption
Beschrijving

Malabsorption Absent | Absence Gastrointestinal Disease Effect Drug absorption

Datatype

boolean

Alias
UMLS CUI [1,1]
C3714745
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C0017178
UMLS CUI [2,3]
C1280500
UMLS CUI [2,4]
C0678745
life expectancy: more than 12 weeks.
Beschrijving

Life Expectancy

Datatype

boolean

Alias
UMLS CUI [1]
C0023671
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous usage of her/egfr inhibitors or other target molecule drugs ( small molecule drugs or monoclonal antibody therapy )
Beschrijving

HER2 Inhibitor | EGFR inhibitor | Target Molecule Agent | Small Molecule Agent | Monoclonal Antibody Therapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0069515
UMLS CUI [1,2]
C1999216
UMLS CUI [2]
C1443775
UMLS CUI [3,1]
C1521840
UMLS CUI [3,2]
C0567416
UMLS CUI [3,3]
C1254351
UMLS CUI [4,1]
C1328819
UMLS CUI [4,2]
C1254351
UMLS CUI [5]
C0279694
patients requires liver shunt , stent placement, or radiotherapy when 2 weeks before the start of the study or research process .
Beschrijving

Patient need for Liver Shunt | Patient need for Placement of stent | Patient need for Therapeutic radiology procedure

Datatype

boolean

Alias
UMLS CUI [1,1]
C0686904
UMLS CUI [1,2]
C0023884
UMLS CUI [1,3]
C0542331
UMLS CUI [2,1]
C0686904
UMLS CUI [2,2]
C0522776
UMLS CUI [3,1]
C0686904
UMLS CUI [3,2]
C1522449
patients with active hepatitis and cirrhosis.
Beschrijving

Hepatitis | Liver Cirrhosis

Datatype

boolean

Alias
UMLS CUI [1]
C0019158
UMLS CUI [2]
C0023890
Terug naar het begin van de pagina

Similar models

Eligibility Non-small Cell Lung Cancer NCT02062515

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma TNM clinical staging | Patients Inappropriate Operative Surgical Procedures | Patients Inappropriate Therapeutic radiology procedure
Item
histologically or cytologically confirmed diagnosis of iiib/iv stage nsclc patients who are not suitable for surgery or radiotherapy
boolean
C0007131 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C0030705 (UMLS CUI [2,1])
C1548788 (UMLS CUI [2,2])
C0543467 (UMLS CUI [2,3])
C0030705 (UMLS CUI [3,1])
C1548788 (UMLS CUI [3,2])
C1522449 (UMLS CUI [3,3])
ECOG performance status
Item
ecog performance status points (ps) is 0-2
boolean
C1520224 (UMLS CUI [1])
Liver function
Item
liver function:
boolean
C0232741 (UMLS CUI [1])
Liver dysfunction, mild
Item
a (mild hepatic dysfunction):
boolean
C3279149 (UMLS CUI [1])
Serum bilirubin normal | Aspartate aminotransferase increased
Item
a1) total bilirubin within normal limit (uln), while ast> uln;
boolean
C0428443 (UMLS CUI [1])
C0151904 (UMLS CUI [2])
Elevated total bilirubin
Item
a2) total bilirubin within1.0-1 .5 × uln;
boolean
C0741494 (UMLS CUI [1])
Liver Dysfunction Moderate | Elevated total bilirubin
Item
b (moderate hepatic dysfunction): total bilirubin within1.5-3 .0 × uln
boolean
C0086565 (UMLS CUI [1,1])
C0205081 (UMLS CUI [1,2])
C0741494 (UMLS CUI [2])
Malabsorption Absent | Absence Gastrointestinal Disease Effect Drug absorption
Item
no malabsorption or other gastrointestinal disorders effecting drug absorption
boolean
C3714745 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0332197 (UMLS CUI [2,1])
C0017178 (UMLS CUI [2,2])
C1280500 (UMLS CUI [2,3])
C0678745 (UMLS CUI [2,4])
Life Expectancy
Item
life expectancy: more than 12 weeks.
boolean
C0023671 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
HER2 Inhibitor | EGFR inhibitor | Target Molecule Agent | Small Molecule Agent | Monoclonal Antibody Therapy
Item
previous usage of her/egfr inhibitors or other target molecule drugs ( small molecule drugs or monoclonal antibody therapy )
boolean
C0069515 (UMLS CUI [1,1])
C1999216 (UMLS CUI [1,2])
C1443775 (UMLS CUI [2])
C1521840 (UMLS CUI [3,1])
C0567416 (UMLS CUI [3,2])
C1254351 (UMLS CUI [3,3])
C1328819 (UMLS CUI [4,1])
C1254351 (UMLS CUI [4,2])
C0279694 (UMLS CUI [5])
Patient need for Liver Shunt | Patient need for Placement of stent | Patient need for Therapeutic radiology procedure
Item
patients requires liver shunt , stent placement, or radiotherapy when 2 weeks before the start of the study or research process .
boolean
C0686904 (UMLS CUI [1,1])
C0023884 (UMLS CUI [1,2])
C0542331 (UMLS CUI [1,3])
C0686904 (UMLS CUI [2,1])
C0522776 (UMLS CUI [2,2])
C0686904 (UMLS CUI [3,1])
C1522449 (UMLS CUI [3,2])
Hepatitis | Liver Cirrhosis
Item
patients with active hepatitis and cirrhosis.
boolean
C0019158 (UMLS CUI [1])
C0023890 (UMLS CUI [2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial